New Molecule Discovered

TK216 was discovered in 2014 based on the work of Jeffrey A Toretsky, MD, at Georgetown University, who identified a research molecule that was shown to kill Ewing sarcoma cells and inhibit growth of tumors in preclinical studies. The clinical molecule, TK216, has been extensively evaluated in preclinical studies, where it has been shown to kill ES cells and inhibit tumor growth.